Human Epidermal Growth Factor Receptor 2 (HER2)-Ultralow Breast Cancer: Incidence, Clinicopathologic Features, and Need for Refined Scoring System is a research paper published in Modern Pathology (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Research Foundation
Grant: 17-287
US Food and Drug Administration
Grant: 1U01FD007909-01A1
Breast Cancer Research Foundation
Grant: 25-20-26-PARE
FDA HHS
Grant: U01 FD007909
NCI NIH HHS
Grant: P50 CA247749
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Foundation for the National Institutes of Health
National Cancer Institute
United States and Canadian Academy of Pathology
MeSH Terms
Keywords